Literature DB >> 7076872

Comparative epidemiology of gentamicin-resistant enterobacteria: persistence of carriage and infection.

C A Hart, M F Gibson.   

Abstract

During a two-year period from January 1979, 260 patients have been involved in an outbreak of carriage and infection due to gentamicin-resistant enterobacteria. We have examined the duration of carriage of such enterobacteria and have compared the carriage of Klebsiella with that of other resistant enterobacteria. Carriage of gentamicin-resistant enterobacteria occurred most frequently and was least sporadic in the intestinal tract. Vaginal carriage was observed in 49 out of 68 patients tested and occurred more frequently in older patients. Oral carriage was noted in 36% of patients but was more sporadic than intestinal carriage. Rates of oral carriage were greater among moribund patients. Carriage at skin sites was related to their proximity to the perineum. Intestinal carriage of gentamicin-resistant Escherichia coli and Klebsiellae but not Klebsiella oxytoca nor Citrobacter persisted for long periods (half lives of 140 and 100 days respectively). Cessation of carriage of gentamicin-resistant Klebsiellae was due to loss of both the organism and its plasmid rather than a shedding of the plasmid. Chronic bacteriuria with gentamicin-resistant E coli and Klebsiellae (half life 180 days) but not Klebsiella oxytoca nor Citrobacter persisted for long periods.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076872      PMCID: PMC497680          DOI: 10.1136/jcp.35.4.452

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Titres and cross reactions of commercial antisera for the capsular typing of Klebsiella species.

Authors:  M W Casewell
Journal:  J Clin Pathol       Date:  1975-01       Impact factor: 3.411

2.  Microbial flora of the vagina and cervix.

Authors:  C M Corbishley
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

3.  A hospital epidemic caused by gentamicin-resistant Klebsiella aerogenes.

Authors:  K Curie; D C Speller; R A Simpson; M Stephens; D I Cooke
Journal:  J Hyg (Lond)       Date:  1978-02

4.  Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli.

Authors:  W G Johanson; A K Pierce; J P Sanford
Journal:  N Engl J Med       Date:  1969-11-20       Impact factor: 91.245

5.  Nosocomial klebsiella infections: intestinal colonization as a reservoir.

Authors:  R Selden; S Lee; W L Wang; J V Bennett; T C Eickhoff
Journal:  Ann Intern Med       Date:  1971-05       Impact factor: 25.391

6.  Klebsiella serotyping by counter-current immunoelectrophoresis.

Authors:  J M Palfreyman
Journal:  J Hyg (Lond)       Date:  1978-10

7.  A Klebsiella screening medium.

Authors:  T J Donovan
Journal:  J Med Lab Technol       Date:  1966-07

8.  An investigation into the incidence and sources of klebsiella infections in hospital patients.

Authors:  E M Cooke; J C Brayson; A S Edmondson; D Hall
Journal:  J Hyg (Lond)       Date:  1979-06

9.  Further studies on the sources of Klebsiella aerogenes in hospital patients.

Authors:  E M Cooke; R Pool; J C Brayson; A S Edmondson; M E Munro; R Shinebaum
Journal:  J Hyg (Lond)       Date:  1979-12

10.  Gentamicin-resistant Klebsiella aerogenes in a urological ward.

Authors:  M W Casewell; M T Dalton; M Webster; I Phillips
Journal:  Lancet       Date:  1977-08-27       Impact factor: 79.321

View more
  2 in total

1.  Molecular analysis of multiple-resistance plasmids transferred from gram-negative bacteria isolated in a urological unit.

Authors:  H G Griffin; T J Foster; F R Falkiner; M E Carr; D C Coleman
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

2.  HIGH PREVALENCE OF MULTI-DRUG RESISTANT KLEBSIELLA PNEUMONIAE IN A TERTIARY TEACHING HOSPITAL IN WESTERN KENYA.

Authors:  Ogalo Edith Apondi; Owuor Chrispine Oduor; Boor Kipyego Gye; Mutai Kennedy Kipkoech
Journal:  Afr J Infect Dis       Date:  2016-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.